Our study revealed the critical role of SPDEF in promoting PAAD by upregulating S100A16 transcription and stimulating the PI3K/AKT signaling pathway, thereby deepening the understanding of the molecular evolution of pancreatic cancer and revealing new therapeutic targets in the SPDEF-driven pathways. This evidence concerns the gene S100A16 and pancreatic neoplasm.